Bain Capital

Astronomer, Inc. is a company based in Cincinnati, Ohio, that specializes in developing a managed platform for data orchestration, primarily utilizing Apache Airflow. Established in 2014, Astronomer offers a comprehensive suite of products and services through its platform, known as Astro. This platform is designed to streamline the process of building, running, and monitoring data pipelines-as-code, catering to the needs of data engineers, scientists, and analysts. By providing tools for deploying, managing, and scaling data workflows, Astronomer enhances the availability of trusted data for organizations, making it easier for data teams to conduct business analytics effectively. As a commercial developer of Airflow, Astronomer plays a significant role in the data orchestration landscape, serving hundreds of thousands of teams globally.

Lincoln Financial Group is a Fortune 500 insurance and financial services company based in Radnor, Pennsylvania, established in 1905 with the endorsement of Robert Todd Lincoln, the son of Abraham Lincoln. The company is dedicated to providing a wide range of products, including life insurance, annuities, retirement plan services, and group protection. It focuses on wealth protection, accumulation, and retirement income solutions, aiming to help individuals secure better futures for themselves and their families. With over a century of experience, Lincoln Financial Group has built its reputation on the principles and ideals associated with Abraham Lincoln, emphasizing honesty and dependability in its financial services.

Sizzling Platter, LLC is a food and beverage company that owns and manages a diverse range of fast casual restaurants in the United States and internationally. Founded in 1963 and headquartered in Murray, Utah, the company offers a variety of menu items, including pizzas, donuts, coffee, burgers, steak, seafood, and salads. Sizzling Platter focuses on acquiring and supporting various restaurant brands, providing them with the resources needed for growth and enhanced return on capital. The company is committed to delivering a quick service and casual dining experience at affordable prices, while also engaging in community initiatives such as donating food to those in need.

HealthEdge is a technology company that provides an integrated software platform designed for healthcare payors. Founded in December 2004 by Albert Waxman and Rob Gillette, HealthEdge specializes in delivering innovative solutions that help health insurers enhance operational efficiency, improve patient outcomes, and significantly lower administrative costs. The company's flagship product suite, HealthRules, is built on patented technology and can be deployed via the HealthEdge Cloud or on-premises. This platform encompasses various functionalities, including claims and benefits administration, care management, and business intelligence, enabling clients to adopt new business models and streamline processes within the healthcare delivery system. In 2012, HealthEdge expanded its offerings by acquiring Click4Care, which enhanced its capabilities in clinical care management. Headquartered in Burlington, Massachusetts, HealthEdge also has a research and development center in Powell, Ohio.

LightSource develops a supply chain management platform to help professionals collaborate with their suppliers. It also allows collaborating with teammates on strategic sourcing projects, sending RFQs to suppliers and collecting quotes, and comparing bids using insights automatically extracted from the normal day-to-day work. The company was founded in 2021 and is headquartered in San Francisco, California.

HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.

Surf Internet offers fiber and fixed wireless broadband services to residential and business customers in Indiana, Illinois, and Michigan. The company provides a variety of internet plans tailored to different usage needs, ensuring reliable connectivity for activities such as streaming, gaming, and remote work. In addition to broadband internet, Surf Internet also offers digital phone services. The company is committed to expanding its network infrastructure to improve service availability and performance while prioritizing customer support for installation and technical issues. Through its efforts, Surf Internet aims to enhance the quality of life in the Great Lakes region by delivering high-speed internet solutions to communities.

Solid Biosciences Inc. is a life science company focused on developing therapies for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys. The company's lead product candidate, SGT-001, is a gene transfer therapy currently undergoing a Phase I/II clinical trial aimed at restoring functional dystrophin protein expression in patients' muscles. In addition to SGT-001, Solid Biosciences is advancing the Anti-LTBP4 program, which involves a monoclonal antibody designed to reduce fibrosis and inflammation by targeting the LTBP4 protein. The company also develops biomarkers and sensors, as well as the Solid Suit program, which focuses on creating wearable assistive devices with functional and therapeutic benefits. Founded in 2013 and headquartered in Cambridge, Massachusetts, Solid Biosciences has established a strategic collaboration with Ultragenyx to enhance gene therapy development for DMD. With no current cure for DMD, the company aims to provide innovative solutions for a condition that affects an estimated 10,000 to 15,000 cases in the United States.

Abcuro, Inc. is a biotechnology company focused on developing immunotherapies for the treatment of autoimmunity and cancer. Based in Newton, Massachusetts, Abcuro creates therapeutic antibodies targeting novel mechanisms related to these diseases. The company utilizes advanced bioinformatics to analyze transcription data from human diseases, which aids in the identification of new therapeutic targets. Through ex-vivo validation in diseased tissues, Abcuro seeks to uncover innovative methods to modulate key components of the immune system. Established in 2015, Abcuro aims to enhance treatment strategies in the healthcare industry by offering effective solutions for complex immunological conditions.

SelectQuote Insurance Services, Inc. is an insurance company based in San Francisco, California, specializing in a diverse array of insurance products, including term life, auto, home, and Medicare insurance. Founded in 1985, SelectQuote aims to assist families by providing tailored insurance solutions that meet their specific needs and budget. Operating as a subsidiary of SelectQuote, Inc., the company utilizes a direct-to-consumer distribution model, allowing clients to compare rates from a wide range of highly rated insurance providers online. This approach ensures that consumers receive the best possible coverage at competitive prices. SelectQuote generates revenue through commissions earned by selling insurance products on behalf of its carrier partners and operates through four key segments: Senior, Healthcare Services, Life, and Auto & Home.

Mitsubishi Tanabe Pharma Corporation is a pharmaceutical company headquartered in Osaka, Japan, that manufactures and sells a diverse range of drugs across Japan, Europe, North America, and other Asian countries. The company focuses on developing treatments for various medical conditions, including immuno-inflammation, diabetes, kidney diseases, and central nervous system disorders. Its notable products include Simponi for rheumatoid arthritis, multiple diabetes treatments such as Canaglu and Invokana, Radicava for amyotrophic lateral sclerosis, and Gilenya for multiple sclerosis. Additionally, Mitsubishi Tanabe Pharma offers vaccines, including influenza and varicella vaccines, and over-the-counter products. The company collaborates with several organizations to enhance its research and development capabilities. Founded in 1678, it operates as a subsidiary of Mitsubishi Chemical Holdings Corporation.

Milacron Holdings is a prominent manufacturer and distributor of highly engineered and customized systems within the plastic technology and processing industry, which is valued at approximately $27 billion. The company offers a comprehensive product portfolio that includes injection molding, blow molding, extrusion equipment, and hot runner systems, positioning itself as the only global entity with such a full-line offering. Milacron's operations are divided into three segments: Advanced Plastic Processing Technologies, Melt Delivery and Control Systems, and Fluid Technologies. The Advanced Plastic Processing Technologies segment focuses on the design and manufacture of various molding equipment and related services, while the Melt Delivery and Control Systems segment produces hot runner and process control systems, along with maintenance, repair, and operating supplies for plastic processing equipment. The Fluid Technologies segment specializes in synthetic and semi-synthetic lubricants and coolants for industrial metalworking applications. With a diverse customer base exceeding 27,000, Milacron maintains strong market shares in North America and emerging markets like China and India.

Cofactr, founded in 2021 by Matthew Haber and Phillip Gulley in New York, specializes in supply chain automation and procurement optimization for critical industries such as aerospace, defense, medtech, and robotics. The company offers an automated electronics purchasing assistant that aids hardware teams in sourcing necessary components by connecting them with global suppliers. Cofactr's platform features powerful supply chain intelligence, intuitive forecasting, transparent search capabilities, automated quoting, and instant purchasing. By streamlining these processes, Cofactr enables clients to proactively address sourcing challenges and reduce supply issues, ensuring the timely delivery of essential hardware.

AutoComplete, Inc. is an insurance-technology company located in San Francisco, California, focused on transforming the car insurance market, which is valued at $311 billion. The company has developed an artificial intelligence platform that aims to simplify the auto insurance process, providing users with a streamlined experience. By leveraging AI technology, AutoComplete enables users to obtain auto protection with minimal effort, enhancing the overall customer experience in automotive insurance.

Kestra Medical Technologies, Inc. specializes in the development and manufacturing of wearable medical devices designed for monitoring and managing acute medical conditions. Founded in 2014 and based in Kirkland, Washington, the company offers solutions that collect, communicate, and store patient performance data, enabling both real-time and retrospective analysis. Among its products are wearable cardioverter defibrillators, which aim to prevent sudden cardiac death and facilitate cardiac recovery in at-risk patients. Kestra Medical Technologies focuses on creating intuitive and mobile diagnostic and therapeutic technologies that support healthcare providers and enhance patient care.

Momento was founded with the vision to enable developers to write reliable and powerful apps faster than ever thought possible. Momento removes the need to manage caches by providing a serverless caching solution that works at any scale, so developers can concentrate on doing what they love: developing better products and services, faster. Momento is a team of distributed systems and database experts. The company is headquartered out of Seattle, Washington with a team that is distributed worldwide. Visit gomomento.com for more information—or see just how fast and simple it is to get going with Momento by starting for free at start.gomomento.com.

Cube Dev, Inc. is a San Francisco-based company that specializes in designing and developing an open-source analytical API platform. The company's offerings include tools for building user interfaces, analytical API servers, and support for modern data stores. Their flagship product, Cube Cloud, serves as a semantic layer that helps organizations manage and optimize their analytics workflows by unifying business logic, centralizing governance and security, and enhancing query performance. Cube Cloud is equipped to handle significant data volumes and provides built-in security, allowing clients to efficiently fetch data rather than relying on pre-built visualizations. Established in 2016, Cube Dev aims to empower businesses to build both internal business intelligence tools and customer-facing analytics capabilities.

CereVasc, Inc. is a medical device company dedicated to developing innovative, minimally invasive treatments for neurological diseases. Founded in 2014 and based in Auburndale, Massachusetts, the company focuses on its flagship product, the eShunt System. This system provides an endovascularly deliverable cerebrospinal fluid shunt along with necessary delivery components, designed to eliminate the need for invasive surgical procedures, general anesthesia, and prolonged hospitalization associated with traditional treatments for communicating hydrocephalus. By offering a less invasive option, the eShunt System aims to enhance patient outcomes and reduce the overall costs of surgical interventions for this serious condition.

Sikich is a Chicago-based accounting firm established in 1982 that provides a wide range of services, including accounting, auditing, tax planning, and information technology managed services. The firm also has a dedicated investment banking division that specializes in mergers and acquisitions, as well as capital raising for corporations, private equity firms, and entrepreneurs. Sikich serves various sectors, including healthcare and life sciences, agriculture, construction, manufacturing, technology, education, and retail, offering tailored financial and strategic advisory services to meet the unique needs of its clients.

Century Therapeutics, Inc. is a biotechnology company focused on developing innovative cell therapies derived from induced pluripotent stem cells (iPSCs) to treat hematologic and solid malignancies. Founded in 2018 and headquartered in Philadelphia, Pennsylvania, the company utilizes a specialized platform that integrates gene editing and protein engineering to create allogeneic therapies. This platform allows for the generation of master cell banks of modified immune effector cells, specifically engineered to optimize performance and reduce the risk of rejection by the host immune system. By employing advanced technologies such as CRISPR-mediated gene editing and proprietary chimeric antigen receptors, Century Therapeutics aims to address significant unmet medical needs in cancer and other diseases.

Xilio Therapeutics is a clinical-stage biotechnology company focused on developing innovative immunotherapies to enhance the immune system's ability to combat cancer. The company specializes in tumor-selective immunotherapies that leverage its proprietary technology to maximize the effectiveness of existing immuno-oncology treatments while minimizing side effects outside the tumor. Its lead product, XTX201, is designed to induce immune activity specifically within tumors, demonstrating improved antitumor efficacy. Xilio Therapeutics aims to deliver significant improvements in patient outcomes by utilizing its platform to create a pipeline of novel therapies, including tumor-activated cytokines, antibodies, and immune cell engagers, all targeted to optimize therapeutic effects within the tumor microenvironment. Founded in 2015 and based in Waltham, Massachusetts, the company was previously known as Akrevia Therapeutics before rebranding in March 2020.

Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.

Solid Biosciences Inc. is a life science company focused on developing therapies for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys. The company's lead product candidate, SGT-001, is a gene transfer therapy currently undergoing a Phase I/II clinical trial aimed at restoring functional dystrophin protein expression in patients' muscles. In addition to SGT-001, Solid Biosciences is advancing the Anti-LTBP4 program, which involves a monoclonal antibody designed to reduce fibrosis and inflammation by targeting the LTBP4 protein. The company also develops biomarkers and sensors, as well as the Solid Suit program, which focuses on creating wearable assistive devices with functional and therapeutic benefits. Founded in 2013 and headquartered in Cambridge, Massachusetts, Solid Biosciences has established a strategic collaboration with Ultragenyx to enhance gene therapy development for DMD. With no current cure for DMD, the company aims to provide innovative solutions for a condition that affects an estimated 10,000 to 15,000 cases in the United States.

MaintainX, Inc. is a technology company that specializes in a frontline record management platform designed for maintenance and facility management teams. Launched in 2018 and based in San Francisco, California, MaintainX provides a software as a service (SaaS) solution that digitizes workflows, enhances collaboration, and offers analytics to streamline maintenance operations. The platform includes features such as environmental and training checklists, tooling and gauge reporting, auditing workflows, and quality control inspections. Additionally, it facilitates communication among users and allows for photo uploads to enhance operational efficiency. MaintainX serves a diverse range of industries, including manufacturing facilities, restaurants, and hotels, focusing on improving asset management and ensuring regulatory compliance.

Gynesonics, Inc. is a medical device company that focuses on designing and developing minimally invasive solutions for symptomatic uterine fibroids in women. Established in 2005 and headquartered in Redwood City, California, with an additional location in Beuningen, the Netherlands, the company offers the Sonata System, which utilizes sonography-guided transcervical fibroid ablation for the treatment of fibroids under intrauterine sonography guidance. Gynesonics aims to provide a safe and effective incisionless alternative to traditional surgical techniques such as hysterectomy and myomectomy, thereby enabling women to receive painless treatments for severe menstrual symptoms associated with fibroids.

Nimbus Therapeutics, based in Cambridge, Massachusetts, is a biotechnology company focused on discovering and developing innovative medicines for serious diseases, including metabolic disorders, cancer, and immune-inflammatory conditions. The company utilizes advanced computational technologies to create selective and potent small-molecule therapeutics. Among its notable projects is the Nimbus Apollo program, which features the lead candidate NDI-010976, an allosteric inhibitor targeting Acetyl-CoA Carboxylase (ACC). This compound is being developed for the treatment of non-alcoholic steatohepatitis (NASH) and has potential applications in hepatocellular carcinoma (HCC) and other diseases. NDI-010976 received Fast Track designation from the U.S. Food and Drug Administration in 2016, highlighting its significance in the clinical development pipeline. Nimbus Therapeutics has formed strategic partnerships to enhance its research and development capabilities, reinforcing its commitment to advancing treatment options for complex health challenges.

Cofactr, founded in 2021 by Matthew Haber and Phillip Gulley in New York, specializes in supply chain automation and procurement optimization for critical industries such as aerospace, defense, medtech, and robotics. The company offers an automated electronics purchasing assistant that aids hardware teams in sourcing necessary components by connecting them with global suppliers. Cofactr's platform features powerful supply chain intelligence, intuitive forecasting, transparent search capabilities, automated quoting, and instant purchasing. By streamlining these processes, Cofactr enables clients to proactively address sourcing challenges and reduce supply issues, ensuring the timely delivery of essential hardware.

Alkeus Pharmaceuticals is a Boston-based clinical-stage biopharmaceutical company dedicated to developing treatments for serious and untreatable ophthalmic conditions. The company's primary focus is on its lead drug candidate, an orally delivered compound aimed at addressing Stargardt disease and age-related macular degeneration. This innovative treatment has the potential to help medical professionals manage symptoms of irreversible vision loss early in life, offering hope to patients affected by these debilitating eye diseases.

HeartFlow, Inc. is a medical technology company that specializes in non-invasive solutions for coronary artery disease detection. Founded in 2007 and based in Redwood City, California, with additional offices in Portland, Austin, London, and Tokyo, the company offers its HeartFlow Analysis, which utilizes data from standard computerized tomography scans to create personalized three-dimensional models of a patient's heart. This analysis helps clinicians evaluate the impact of blockages on blood flow, facilitating informed treatment decisions while minimizing the need for invasive testing. HeartFlow's technology integrates over two decades of scientific research with advancements in artificial intelligence, making its HeartFlow FFRCT Analysis available in the United States, Canada, Europe, the United Kingdom, and Japan.

MeTEOR Education LLC is a company based in Gainesville, Florida, that specializes in the development of learning environments and furnishings for educational institutions across the United States. Founded in 1967, the company partners with education professionals to create impactful learning experiences tailored to K-12 settings. MeTEOR Education focuses on designing, supplying, and outfitting educational spaces, including common areas, media centers, and STEM labs. In addition to providing physical resources, the company also offers training for teachers to effectively utilize these learning spaces, enhancing student engagement and interaction within academic settings.

Surf Internet offers fiber and fixed wireless broadband services to residential and business customers in Indiana, Illinois, and Michigan. The company provides a variety of internet plans tailored to different usage needs, ensuring reliable connectivity for activities such as streaming, gaming, and remote work. In addition to broadband internet, Surf Internet also offers digital phone services. The company is committed to expanding its network infrastructure to improve service availability and performance while prioritizing customer support for installation and technical issues. Through its efforts, Surf Internet aims to enhance the quality of life in the Great Lakes region by delivering high-speed internet solutions to communities.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on developing innovative treatments for severe hematologic disorders. Founded in 2017, the company specializes in human genetics-based therapeutics that aim to improve red blood cell production in patients suffering from various hematologic diseases. Disc Medicine's pipeline includes therapeutic candidates targeting critical pathways involved in red blood cell biology, such as heme biosynthesis and iron homeostasis. Notable programs include bitopertin, which is being developed for conditions like erythropoietic porphyrias and Diamond-Blackfan anemia. Through its research and development efforts, Disc Medicine seeks to transform the lives of patients affected by these challenging disorders.

Jnana Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, that focuses on drug discovery through its innovative platform targeting solute carrier (SLC) transporters. Established in 2016, the company aims to improve patient outcomes by developing small molecule therapies for various diseases, including those related to immunometabolism, lysosomal function, and mucosal defense. By utilizing advanced chemoproteomics techniques, Jnana accelerates the identification of therapeutic targets, addressing significant unmet medical needs in areas such as immuno-oncology, inflammatory disorders, and neurological diseases. The company's approach seeks to enhance drug discovery efficiency by comprehensively targeting the vast family of membrane proteins associated with SLC transporters.

Momento was founded with the vision to enable developers to write reliable and powerful apps faster than ever thought possible. Momento removes the need to manage caches by providing a serverless caching solution that works at any scale, so developers can concentrate on doing what they love: developing better products and services, faster. Momento is a team of distributed systems and database experts. The company is headquartered out of Seattle, Washington with a team that is distributed worldwide. Visit gomomento.com for more information—or see just how fast and simple it is to get going with Momento by starting for free at start.gomomento.com.

Oort is an identity threat detection and response platform that focuses on enhancing enterprise security. Given that over 60% of security breaches involve the misuse of valid identity credentials, Oort recognizes identity as a critical perimeter that cannot be solely defended by personnel. The platform empowers cybersecurity and IT professionals to effectively manage their identity and access management (IAM) programs, providing full visibility and control over their identity attack surface. Oort's SaaS solution is designed for rapid deployment, allowing organizations to quickly reduce identity vulnerabilities at scale. Additionally, it offers network solutions through a network of globally distributed data centers, ensuring robust security for the digital supply chain. Based in Boston, MA, Oort operates as a fully remote startup and is supported by prominent investors such as Bain Capital Ventures, 645 Ventures, and First Star Ventures.

Oort is an identity threat detection and response platform that focuses on enhancing enterprise security. Given that over 60% of security breaches involve the misuse of valid identity credentials, Oort recognizes identity as a critical perimeter that cannot be solely defended by personnel. The platform empowers cybersecurity and IT professionals to effectively manage their identity and access management (IAM) programs, providing full visibility and control over their identity attack surface. Oort's SaaS solution is designed for rapid deployment, allowing organizations to quickly reduce identity vulnerabilities at scale. Additionally, it offers network solutions through a network of globally distributed data centers, ensuring robust security for the digital supply chain. Based in Boston, MA, Oort operates as a fully remote startup and is supported by prominent investors such as Bain Capital Ventures, 645 Ventures, and First Star Ventures.

Solid Biosciences Inc. is a life science company focused on developing therapies for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys. The company's lead product candidate, SGT-001, is a gene transfer therapy currently undergoing a Phase I/II clinical trial aimed at restoring functional dystrophin protein expression in patients' muscles. In addition to SGT-001, Solid Biosciences is advancing the Anti-LTBP4 program, which involves a monoclonal antibody designed to reduce fibrosis and inflammation by targeting the LTBP4 protein. The company also develops biomarkers and sensors, as well as the Solid Suit program, which focuses on creating wearable assistive devices with functional and therapeutic benefits. Founded in 2013 and headquartered in Cambridge, Massachusetts, Solid Biosciences has established a strategic collaboration with Ultragenyx to enhance gene therapy development for DMD. With no current cure for DMD, the company aims to provide innovative solutions for a condition that affects an estimated 10,000 to 15,000 cases in the United States.

Nimbus Therapeutics, based in Cambridge, Massachusetts, is a biotechnology company focused on discovering and developing innovative medicines for serious diseases, including metabolic disorders, cancer, and immune-inflammatory conditions. The company utilizes advanced computational technologies to create selective and potent small-molecule therapeutics. Among its notable projects is the Nimbus Apollo program, which features the lead candidate NDI-010976, an allosteric inhibitor targeting Acetyl-CoA Carboxylase (ACC). This compound is being developed for the treatment of non-alcoholic steatohepatitis (NASH) and has potential applications in hepatocellular carcinoma (HCC) and other diseases. NDI-010976 received Fast Track designation from the U.S. Food and Drug Administration in 2016, highlighting its significance in the clinical development pipeline. Nimbus Therapeutics has formed strategic partnerships to enhance its research and development capabilities, reinforcing its commitment to advancing treatment options for complex health challenges.

JenaValve Technology, Inc., established in 2006, specializes in developing and manufacturing transcatheter aortic valve replacement (TAVR) systems. Its flagship product, the Trilogy™ Heart Valve System, is designed to treat high-risk patients with symptomatic, severe aortic regurgitation and aortic stenosis. The system, which received CE Mark approval in 2021, features a porcine pericardial trileaflet valve mounted on a low-profile nitinol self-expanding frame with integral locators that engage with the native valve cusps. JenaValve operates globally, with headquarters in Irvine, California, and additional locations in Munich, Germany, and Leeds, United Kingdom.

Properly Inc. is a Canadian real estate brokerage founded in 2018 and headquartered in Toronto. The company specializes in buying and selling residential properties, utilizing a technology-driven platform designed to enhance the home buying and selling experience. Properly's innovative approach allows clients to purchase a new home before listing their current one, offering the option of securing a backup offer. The platform employs machine learning to accurately assess market values for homes, streamlining the transaction process. By providing a user-friendly online interface, Properly aims to simplify real estate transactions and accommodate the timelines of its clients.

Latchel, Inc. is a technology company that specializes in providing an online platform for maintenance coordination tailored for property managers and landlords. Founded in 2016 and located in Bellevue, Washington, Latchel's software allows property management companies to efficiently track maintenance requests, select vendors, and enhance tenant satisfaction. The platform facilitates communication between tenants and property managers through a mobile application, enabling residents to schedule maintenance and address tasks promptly. By streamlining operations, Latchel aims to improve net margins for property managers and elevate the overall quality of maintenance services offered to residents.

Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.

X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, specializing in the discovery and development of innovative therapeutics for primary immune deficiencies and cancer. The company's lead drug candidate, mavorixafor, is an oral small molecule antagonist of the chemokine receptor CXCR4, currently undergoing multiple clinical trials. These include a Phase III trial for patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome, as well as Phase Ib and Phase IIa trials focused on severe congenital neutropenia and clear cell renal cell carcinoma, respectively. In addition, X4 Pharmaceuticals is advancing X4P-002, targeting glioblastoma multiforme, and X4P-003 aimed at primary immune deficiencies. The company has also established a license agreement with Abbisko Therapeutics to develop mavorixafor in combination with checkpoint inhibitors for oncology applications. Founded in 2014, X4 Pharmaceuticals was previously known as Arsanis, Inc. before rebranding in March 2019.

Grid.ai, Inc. is a technology company that provides a platform for training artificial intelligence (AI) models using cloud-based graphics processing units (GPUs) and tensor processing units (TPUs). Founded in 2019 and headquartered in New York, the company offers tools such as Grid Train, which facilitates AI research by simplifying model training and iteration, and Grid View, a web application for monitoring and managing infrastructure. Additionally, it provides Tensorboard for experiment analysis. Grid.ai aims to support machine learning engineers, data scientists, and AI researchers by enabling the development of advanced AI models and end-to-end machine learning systems, known as Lightning Apps, that are multi-cloud and fault-tolerant. The company gained significant funding in October 2020, which has bolstered its mission to enhance AI capabilities for users.

HYCU is a leading provider of multi-cloud and SaaS data protection services, specializing in data backup and recovery solutions for on-premises, cloud-native, and SaaS environments. The company's R-Cloud platform streamlines data protection, migration, disaster recovery, and ransomware protection, addressing the complexities and costs associated with traditional data management solutions. By offering a comprehensive and user-friendly approach, HYCU aims to simplify the data monitoring and protection process for multi-cloud data centers. With a strong commitment to customer satisfaction, reflected in an impressive Net Promoter Score, HYCU has established itself as a trusted partner for thousands of companies worldwide. The company is headquartered in Boston, Massachusetts, and has secured significant venture capital funding to support its growth and innovation in the data protection landscape.

Cuisine Solutions is a United States-based company specializing in the production and marketing of sous-vide products and fully-cooked, frozen foods. Their diverse product range includes beef, lamb, pork, veal, poultry, seafood, and a variety of sauces and vegetarian options. The company caters to various channels and geographic regions, focusing on providing high-quality prepared foods that meet consumer demand for convenience and flavor.

JupiterOne, Inc. develops cloud-based cybersecurity asset management and automation software aimed at enhancing security and compliance for organizations. The company's flagship product provides chief information security officers, security operations teams, and compliance officers with tools to automate the discovery, visibility, and management of cyber assets across cloud environments. This includes functionalities for risk analysis, compliance reporting, vulnerability management, threat hunting, and incident response. Additionally, the JupiterOne Insights application allows users to create customized reporting dashboards and visualizations for monitoring code activities and security postures. Founded in 2018 and headquartered in Morrisville, North Carolina, JupiterOne operates additional offices in Charlotte, Salt Lake City, and Seattle. The company is a subsidiary of LifeOmic Security, LLC and is focused on simplifying cloud security management for organizations, replacing guesswork with comprehensive data about assets and configurations.

Bubbles is a contextual collaboration tool that enables users to communicate asynchronously by tagging content directly on their screens. The platform facilitates discussions in-context through screen, video, and audio messages, allowing team members to capture, comment, and share information without the need for account creation or installation. Bubbles promotes organic growth and viral engagement rather than relying on paid advertising. It is actively engaged on various social media platforms, including Medium, Twitter, and Product Hunt, to enhance its visibility and user interaction.

Vention Inc. is a digital manufacturing platform based in Montreal, Canada, that simplifies the design and ordering of custom machines. Established in 2016, the company provides a cloud-based 3D Machine Builder, which allows engineers and manufacturing professionals to design, order, and assemble custom factory equipment quickly. This platform features an extensive library of modular parts, including structural, motion, and control components, facilitating the creation of automated equipment, robot cells, tooling, and conveyors. Additionally, Vention's offerings include MachineMotion, which aids both automation specialists and novices in automating their designs. By integrating artificial intelligence to enhance the design process, Vention enables users to program, simulate, and commission automated equipment within a single digital environment, making industrial automation more accessible.

Vertical Harvest is a Wyoming-based agribusiness focused on year-round production of fresh, locally grown produce through hydroponic vertical farming. The company aims to enhance the local economy by providing high-quality food at competitive prices while also addressing food accessibility in underserved communities. By utilizing controlled environment agriculture, Vertical Harvest not only energizes local food systems but also creates inclusive employment opportunities for underserved populations. The initiative encourages the development of underutilized urban spaces, fostering a network of farms that serve local needs and support regional agricultural efforts.

Cofactr, founded in 2021 by Matthew Haber and Phillip Gulley in New York, specializes in supply chain automation and procurement optimization for critical industries such as aerospace, defense, medtech, and robotics. The company offers an automated electronics purchasing assistant that aids hardware teams in sourcing necessary components by connecting them with global suppliers. Cofactr's platform features powerful supply chain intelligence, intuitive forecasting, transparent search capabilities, automated quoting, and instant purchasing. By streamlining these processes, Cofactr enables clients to proactively address sourcing challenges and reduce supply issues, ensuring the timely delivery of essential hardware.

Docker, Inc. is a software company that provides an open platform for building, shipping, and running distributed applications through the use of container technology. Founded in 2008 and headquartered in San Francisco, California, Docker facilitates collaboration among developers and system administrators by allowing applications to be packaged as containers that can run seamlessly across various environments, including local machines, data centers, and public clouds. The platform includes tools for code building, scaling, deployment, and load balancing, as well as a cloud service for sharing applications and automating workflows. By offering an integrated and secure workflow, Docker enhances the efficiency of application development and accelerates the delivery process from code to deployment, serving millions of developers worldwide.

EarnUp Inc. is a fintech company based in San Francisco, California, that focuses on automating loan payments for consumers. Established in 2013, EarnUp's platform is designed to assist over 200 million Americans managing various types of debt, including home mortgages, student loans, auto loans, and personal loans. The platform allows users to set aside small amounts of money when they can afford it, which are then allocated for loan payments, helping users pay off their debts more efficiently. By syncing micro-payments with individual income and automating savings in real-time, EarnUp aims to alleviate the stress of financial management and empower users to take control of their financial situations.

FreeWill Co. is a New York-based company that develops and operates an online estate planning platform. The service offers users access to legal forms and information, simplifying the process of estate planning and facilitating charitable donations. By providing free and user-friendly tools, FreeWill enables donors and fundraisers to make tax-advantaged gifts more easily, streamlining the process of making bequests and donations. The company's mission centers on addressing estate planning needs while promoting philanthropic efforts, ultimately making it simpler for individuals to contribute to charitable organizations.

Decodable is a data integration and engineering platform focused on serverless streaming data, founded in 2021 and based in San Francisco, California. The company provides software that enables applications and data engineers to construct complex data pipelines efficiently. Its platform facilitates quick connections to various messaging, storage, and database systems, allowing users to collect, process, and deliver data effectively to both offline and online systems.

Vesta Corporation is a provider of electronic payment solutions, specializing in client-branded services that enhance payment processing for merchants. The company offers a range of merchant solutions, including vSafe for Small to Midsize Businesses, which focuses on payment and fraud protection for smaller digital goods merchants, and vSafe for Enterprise, designed for comprehensive payments management and enterprise-level fraud prevention. Additionally, Vesta provides vGuaranteed, a payment solution tailored for online retailers, and DelayPay, a retail installment program that allows prepaid wireless customers to pay for services in installments. Founded in 1995 and headquartered in Lake Oswego, Oregon, Vesta operates globally, with centers in the United States, Ireland, China, and an office in Singapore. The company serves diverse industries, including e-commerce, telecommunications, and financial services, processing hundreds of millions of secure payments across various channels while prioritizing data security and fraud loss elimination.

Soona is a virtual content studio founded in 2018 by Liz Giorgi and Hayley Anderson in Denver, Colorado. The company specializes in providing professional-level photo and video services tailored for e-commerce and marketing needs. Soona offers a diverse range of content solutions, including vlogs, brand shots, team photos, and green screen productions. By focusing on affordability and quality, Soona enables brands to create compelling visual content that effectively promotes their products and services.

Clockwise Inc. is a San Francisco-based company that specializes in developing artificial intelligence software for time management. Its flagship product, Clockwise, serves as a smart calendar assistant that connects to users' work calendars at the system level. The software learns individual preferences, such as typical working hours, time zones, and meeting tolerances, to create a more efficient scheduling experience. By analyzing schedules and work habits, Clockwise automatically coordinates meetings and identifies optimal times for focused work, ultimately enhancing productivity and reducing the stress associated with manual calendar management. Founded in 2016, the company aims to bring flexibility to modern workdays, enabling teams to balance collaborative efforts with personal focus time, thereby promoting well-being and preventing burnout.

Zero Hash LLC is a Chicago-based company that provides post-trade settlement services for digital assets, including derivatives and loans. Established in 2017, it offers a range of services such as digital asset storage, settlements, institutional custody, and regulatory compliance, all facilitated through an application programming interface (API). Zero Hash serves various clients, including neo-banks, broker-dealers, and payment groups, enabling them to seamlessly integrate digital asset trading and custody into their platforms. Its turnkey solution simplifies the complexities associated with regulatory licensing and back-end operations, allowing businesses to focus on enhancing customer experiences. Zero Hash’s clients include notable names like MoneyLion, Transak, and MoonPay. The company is supported by investors such as Point72 Ventures and Bain Capital Ventures, emphasizing its role in making digital assets accessible to a broader audience.

Cogsy is an Austin-based startup that offers inventory optimization technology specifically designed for direct-to-consumer (DTC) brands. The platform aims to streamline operations by eliminating the need for manual spreadsheets and guesswork in inventory management. It automatically forecasts sales and predicts optimal stock levels, ensuring that brands maintain the right inventory on hand at all times. By keeping inventory updated in real-time and generating recommended purchase orders, Cogsy enables e-commerce businesses to enhance cash flow and operational efficiency. Additionally, Cogsy provides tools for building custom websites, allowing users to create a tailored online presence easily. Users can utilize simple design tools or request assistance from the support team, while advanced features include a transparent platform for developers to write their own code and create additional functionality for their sites. This comprehensive approach positions Cogsy as a valuable partner for brands looking to optimize their inventory management and online presence.

Sysdig, Inc. is a company specializing in network and application monitoring software solutions that address the challenges of managing cloud-based application delivery infrastructures. Founded in 2013 and headquartered in San Francisco, California, Sysdig offers a cloud-native security and monitoring platform designed for development and operations teams, as well as security professionals. The platform includes a suite of tools, such as a runtime threat detection engine and integrations for Prometheus monitoring, enabling organizations to secure and monitor their containerized applications effectively. Sysdig leverages a unique AI architecture and open-source technology to provide real-time insights, helping teams detect risks and prioritize vulnerabilities, misconfigurations, and threats. With data centers in Oregon and Frankfurt, as well as a subsidiary in Japan, Sysdig empowers enterprises to navigate the complexities of modern cloud-native infrastructures while maintaining application performance, security, and compliance.

Hometap is a fintech company founded in 2018 and based in Boston, Massachusetts, that specializes in home equity investments. It offers homeowners a unique opportunity to access cash without incurring debt or selling their property. By providing immediate funds in exchange for a percentage of the home's future value, Hometap enables homeowners to utilize the money for various purposes, such as paying off debt or financing renovations. This approach allows homeowners to improve their financial situation without the burden of monthly payments or additional loans.

OverIT is a prominent provider of Field Service Management (FSM) software solutions, boasting over 20 years of experience in addressing complex field service challenges for enterprise businesses worldwide. The company serves over 300 clients, enhancing efficiency in linear asset management and facilitating the dispatch of more than 200,000 field workers daily. OverIT specializes in sectors such as energy and utilities, oil and gas, industrial manufacturing, and transportation, offering software that supports system upgrades, field service management, and hardware configurations. Recognized by leading advisory firms like IDC and Gartner, OverIT is acknowledged for its cutting-edge technology and ability to deliver scalable solutions that meet the critical operational needs of its clients.

InnovaCare Health Solutions, LLC is a prominent provider of managed healthcare services in North America, focusing on enhancing access to quality and affordable care. Founded in 1998 and headquartered in Fort Lee, New Jersey, the company offers a range of services including managed care, Medicare plans, and physician network services. InnovaCare operates through two primary avenues: Provider Networks and Medicare Advantage, emphasizing sustainable, cost-effective, and technologically integrated healthcare models. The organization is dedicated to fostering strong patient-provider relationships, which it believes are essential for achieving optimal health outcomes and quality of life. By providing integrated health plans and clinical networks, InnovaCare aims to improve the overall healthcare experience for patients, providers, and stakeholders alike, while maintaining a commitment to transparency and quality in healthcare management.

Socure Inc. is a provider of digital identity verification solutions, focusing on real-time identity authentication through its Socure ID+ platform. This predictive analytics platform utilizes artificial intelligence and machine learning to authenticate identities by analyzing a multitude of online and offline data sources, including email, phone numbers, addresses, IP addresses, and social media profiles. Socure's offerings include Aida, an AI-driven bot for validating digital identities, Docv, an omnichannel document verification solution, and Sigma Synthetic Fraud, which tackles synthetic identity fraud. The company addresses the needs of various sectors, including software, consulting, and financial firms, through compliance initiatives such as customer identification programs, know your customer requirements, and anti-money laundering measures. Founded in 2012 and headquartered in New York, Socure has established partnerships with key industry players to enhance its service delivery.

Cardurion Pharmaceuticals, LLC is a biotechnology company based in Boston, Massachusetts, established in 2017. The company specializes in developing innovative therapeutics aimed at treating heart failure and other cardiovascular diseases. Cardurion is advancing clinical programs that focus on inhibiting PDE9 and CaMKII, utilizing its knowledge of cardiovascular signaling pathways to meet significant patient needs in this area.

Gluware, Inc. is a developer of an Intelligent Network Automation platform that specializes in automating and orchestrating multi-vendor, mission-critical networks. Founded in 2007 and headquartered in Sacramento, California, the company offers a suite of software products, including Gluware Control, a data-model driven platform that uses an intent-based orchestration engine. This platform features tools for configuration compliance, network device software management, and workflow automation, enabling organizations to streamline their network lifecycle management. Key functionalities include monitoring configuration drift, managing software upgrades, and facilitating the coexistence of physical and virtual network functions. Gluware's solutions aim to simplify network complexity, reduce manual deployment costs, and enhance overall network agility, thereby supporting service providers and value-added resellers in delivering enterprise-grade cloud networking services.

Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.

Ginkgo Bioworks is a biotechnology firm based in Boston, Massachusetts, that specializes in designing, engineering, and developing custom microbes and organisms for various applications. Founded in 2008, the company focuses on discovering and licensing molecules used in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. In addition to these capabilities, Ginkgo Bioworks provides probiotic bacteria that help protect against infections and creates extensive libraries of molecules. The firm operates across multiple markets, including cultured ingredients, carbon mitigation, probiotics, and natural product discovery. It has reorganized its operations into two primary segments: Cell Engineering and Biosecurity, with a significant portion of its revenue generated from biosecurity-related data analytics and services.

Wisetack, Inc. is a technology company based in San Francisco, California, that specializes in real-time consumer lending at the point of sale. Founded in 2018, Wisetack offers a platform that allows in-person businesses to provide financing options to customers, enhancing sales opportunities. The platform integrates seamlessly into existing software systems through a suite of APIs, enabling businesses to embed financing solutions directly into their operations. Wisetack facilitates a straightforward sign-up process and checks consumer eligibility before offering installment payment options, thereby simplifying the payment experience for both businesses and their customers.

Cotopaxi is an outdoor gear and apparel company based in Salt Lake City, Utah, founded in 2014. The company operates with a social mission focused on eradicating extreme poverty, linking each product to humanitarian causes in some of the world's poorest regions. For instance, the sale of a travel pack can fund one to three weeks of education for a child, while a water bottle can provide six months of clean water. Cotopaxi offers a diverse range of products, including travel packs, activewear, outerwear, and footwear, all made from responsibly sourced materials. By prioritizing sustainability and transparency, Cotopaxi enables customers to make purchases that not only meet their outdoor needs but also contribute positively to global issues.

Berlin Brands Group (BBG), established in 2005 by Peter Chaljawski, is a global vertical commerce company headquartered in Berlin. It operates across Home & Living, Consumer Electronics, Sound & Light, and Sports sectors, offering over 3,700 products to consumers in 28 countries worldwide. BBG manages the entire value chain of its brands, from product development to customer service, with a team of approximately 900 employees across six locations globally. Its portfolio includes Klarstein, Capital Sports, auna, Blumfeldt, and Numan, catering to modern lifestyle needs through innovative products and online branding expertise.

Cube Dev, Inc. is a San Francisco-based company that specializes in designing and developing an open-source analytical API platform. The company's offerings include tools for building user interfaces, analytical API servers, and support for modern data stores. Their flagship product, Cube Cloud, serves as a semantic layer that helps organizations manage and optimize their analytics workflows by unifying business logic, centralizing governance and security, and enhancing query performance. Cube Cloud is equipped to handle significant data volumes and provides built-in security, allowing clients to efficiently fetch data rather than relying on pre-built visualizations. Established in 2016, Cube Dev aims to empower businesses to build both internal business intelligence tools and customer-facing analytics capabilities.

Properly Inc. is a Canadian real estate brokerage founded in 2018 and headquartered in Toronto. The company specializes in buying and selling residential properties, utilizing a technology-driven platform designed to enhance the home buying and selling experience. Properly's innovative approach allows clients to purchase a new home before listing their current one, offering the option of securing a backup offer. The platform employs machine learning to accurately assess market values for homes, streamlining the transaction process. By providing a user-friendly online interface, Properly aims to simplify real estate transactions and accommodate the timelines of its clients.

Moveworks, Inc. develops a cloud-based AI platform that assists enterprises in resolving IT support issues for their employees. Founded in 2016 and headquartered in Mountain View, California, with an additional office in Culver City, the company offers an AI assistant that automates various tasks, such as ordering hardware, raising software requests, and managing ticket statuses. Utilizing a conversational interface, Moveworks interprets complex employee requests and executes multi-step processes, adapting based on previous interactions. Its technology is employed by organizations like Databricks, Broadcom, Hearst, and Palo Alto Networks to enhance productivity, streamline workflows, and improve information retrieval across enterprise systems. The platform integrates with chat applications, such as Slack, to provide seamless user experiences and automatic solutions.

ShipBob Inc. is a technology company that specializes in providing online shipping and fulfillment services tailored for small e-commerce businesses. Founded in 2014 and headquartered in Chicago, Illinois, ShipBob offers an end-to-end fulfillment solution that includes warehousing, order management, and package delivery, enabling direct-to-consumer brands to ship products within 1-2 business days. Its platform integrates with various e-commerce platforms such as Shopify, Amazon, and eBay, allowing merchants to manage orders, track inventory, and communicate with customers effectively. ShipBob's services encompass pickup, packaging, batch fulfillment, and returns, supported by a network of fulfillment centers across the United States, including a key facility in Dallas, Texas. The company also provides a smartphone application for scheduling pickups and tracking shipments.

Augtera Networks is a technology company that specializes in artificial intelligence solutions for network management. Founded in 2016 and based in Palo Alto, California, Augtera offers an AI-driven platform designed to enhance operations, planning, and orchestration across physical, virtual, and cloud network environments. The platform addresses the challenges of increasing scale and complexity in network management by providing tools for data integration, network modeling, and visualization. It aims to eliminate operational noise, facilitate proactive management, and prevent incidents in enterprise and service provider networks. Augtera's technology is utilized by a range of industries, including cloud services, finance, and telecommunications, enabling clients to automate and optimize their network operations effectively.

ConvenientMD LLC is an urgent care provider that offers a wide range of medical services for non-life-threatening injuries and illnesses. Established in 2011 and headquartered in Portsmouth, New Hampshire, the company caters to patients seeking treatment for conditions such as sprains, fractures, cuts, colds, bronchitis, and urinary tract infections. Additionally, ConvenientMD provides preventive care services, including physicals, immunizations, and on-site prescriptions, as well as X-ray and lab services. Patients can access care without appointments from 8 am to 8 pm, seven days a week, with the expectation of being treated within an hour. The organization emphasizes quality care and customer service, employing a fully equipped medical team at its locations across New Hampshire, Maine, and Massachusetts, with plans for further expansion in New England.

JupiterOne, Inc. develops cloud-based cybersecurity asset management and automation software aimed at enhancing security and compliance for organizations. The company's flagship product provides chief information security officers, security operations teams, and compliance officers with tools to automate the discovery, visibility, and management of cyber assets across cloud environments. This includes functionalities for risk analysis, compliance reporting, vulnerability management, threat hunting, and incident response. Additionally, the JupiterOne Insights application allows users to create customized reporting dashboards and visualizations for monitoring code activities and security postures. Founded in 2018 and headquartered in Morrisville, North Carolina, JupiterOne operates additional offices in Charlotte, Salt Lake City, and Seattle. The company is a subsidiary of LifeOmic Security, LLC and is focused on simplifying cloud security management for organizations, replacing guesswork with comprehensive data about assets and configurations.

Sysdig, Inc. is a company specializing in network and application monitoring software solutions that address the challenges of managing cloud-based application delivery infrastructures. Founded in 2013 and headquartered in San Francisco, California, Sysdig offers a cloud-native security and monitoring platform designed for development and operations teams, as well as security professionals. The platform includes a suite of tools, such as a runtime threat detection engine and integrations for Prometheus monitoring, enabling organizations to secure and monitor their containerized applications effectively. Sysdig leverages a unique AI architecture and open-source technology to provide real-time insights, helping teams detect risks and prioritize vulnerabilities, misconfigurations, and threats. With data centers in Oregon and Frankfurt, as well as a subsidiary in Japan, Sysdig empowers enterprises to navigate the complexities of modern cloud-native infrastructures while maintaining application performance, security, and compliance.

LvlUp Ventures, established in 2019, is a global venture capital firm headquartered in Los Angeles, California. It invests in and accelerates early-stage startups across diverse sectors such as AI, gaming, consumer tech, and fintech, with a presence in major startup hubs worldwide. LvlUp reviews thousands of applications annually, leveraging its extensive ecosystem and industry expertise to support founders and create category-defining companies. The firm offers bespoke acceleration programs, direct investments, and strategic partnerships, with a track record of producing top-quartile companies and a low failure rate.

Cerevel Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapies for neuroscience diseases. Founded in 2018 and headquartered in Cambridge, Massachusetts, the company is advancing a diverse pipeline that includes five clinical-stage investigational therapies and several preclinical compounds targeting conditions such as schizophrenia, epilepsy, Parkinson's disease, and substance use disorder. Key products under development include CVL-231, a positive allosteric modulator for schizophrenia; CVL-865, which is being tested for drug-resistant focal onset epilepsy and acute anxiety; and Tavapadon, a selective dopamine D1/D5 partial agonist for Parkinson's disease. Cerevel Therapeutics employs a unique approach that leverages expertise in neurocircuitry and receptor selectivity to address unmet medical needs in the field of neuroscience.

Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company headquartered in San Diego, California, dedicated to the discovery, development, and commercialization of innovative therapeutics for rare endocrine diseases and endocrine-related tumors. The company’s lead product candidate, paltusotine, is an oral selective nonpeptide somatostatin receptor type 2 biased agonist currently undergoing Phase I clinical trials aimed at treating acromegaly and neuroendocrine tumors. In addition to paltusotine, Crinetics is developing several other therapeutics, including CRN01941, an oral selective nonpeptide sst2 biased agonist for neuroendocrine tumors, and an oral somatostatin type 5 receptor agonist for congenital hyperinsulinism. The company is also working on an oral adrenocorticotrophic hormone antagonist for conditions such as Cushing’s syndrome and congenital adrenal hyperplasia. Founded in 2008, Crinetics Pharmaceuticals is focused on leveraging its internal discovery efforts to create effective treatments while utilizing hormonal biomarker endpoints to enhance the efficiency and cost-effectiveness of its clinical studies.

Hand In Hand Soap, founded in 2011 by Bill Glaab and Courtney Apple, is a personal care brand based in Wynnewood, Pennsylvania. The company is committed to social responsibility through its Give Back program, which ensures that for every product sold, a bar of soap and access to clean water is donated to a child in need. Over the past decade, Hand In Hand has donated over 13 million bars of soap and provided thousands with clean water access. The brand's product range includes bar soap, liquid hand soap, hand sanitizer, body wash, sugar scrubs, and lotions. Additionally, Hand In Hand emphasizes sustainability by producing only palm oil-free products and raising awareness about the environmental and human rights issues associated with palm oil production.

Harry's Inc., established in 2012 and headquartered in New York, specializes in manufacturing and selling men's grooming products. The company produces a range of shaving items including razors, creams, kits, and face care products. Harry's operates an online platform where consumers can purchase these products individually or via a subscription service for convenient access to their grooming essentials.

HYCU is a leading provider of multi-cloud and SaaS data protection services, specializing in data backup and recovery solutions for on-premises, cloud-native, and SaaS environments. The company's R-Cloud platform streamlines data protection, migration, disaster recovery, and ransomware protection, addressing the complexities and costs associated with traditional data management solutions. By offering a comprehensive and user-friendly approach, HYCU aims to simplify the data monitoring and protection process for multi-cloud data centers. With a strong commitment to customer satisfaction, reflected in an impressive Net Promoter Score, HYCU has established itself as a trusted partner for thousands of companies worldwide. The company is headquartered in Boston, Massachusetts, and has secured significant venture capital funding to support its growth and innovation in the data protection landscape.

X4 Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, specializing in the discovery and development of innovative therapeutics for primary immune deficiencies and cancer. The company's lead drug candidate, mavorixafor, is an oral small molecule antagonist of the chemokine receptor CXCR4, currently undergoing multiple clinical trials. These include a Phase III trial for patients with warts, hypogammaglobulinemia, infections, and myelokathexis syndrome, as well as Phase Ib and Phase IIa trials focused on severe congenital neutropenia and clear cell renal cell carcinoma, respectively. In addition, X4 Pharmaceuticals is advancing X4P-002, targeting glioblastoma multiforme, and X4P-003 aimed at primary immune deficiencies. The company has also established a license agreement with Abbisko Therapeutics to develop mavorixafor in combination with checkpoint inhibitors for oncology applications. Founded in 2014, X4 Pharmaceuticals was previously known as Arsanis, Inc. before rebranding in March 2019.

Hi Marley, Inc. is an innovative company based in Boston, Massachusetts, that specializes in enhancing communication within the insurance industry. Founded in 2017, it offers a platform named Marley, which integrates intelligent messaging with a human touch to facilitate seamless interactions between insurance companies and their customers. The platform enables insurers to efficiently manage conversations related to claims, underwriting, and policyholder services, ensuring that customers receive timely updates and responses to their inquiries. By bridging communication gaps, Hi Marley aims to improve customer satisfaction and streamline operations for auto, home, and business insurance providers.

Clari Inc. is a revenue operations platform based in Sunnyvale, California, founded in 2012. The company utilizes automation and artificial intelligence to consolidate and analyze activity data from various business systems, such as CRM, email, calendar, and marketing automation. This integration provides sales professionals with improved visibility into their deals and relationships, enabling them to close deals more efficiently and reduce manual reporting efforts. Clari's platform offers features like Activity Analytics, which delivers predictive insights and real-time data analysis, allowing sales teams and managers to optimize their strategies, enhance coaching, and effectively allocate resources. By streamlining revenue operations, Clari assists B2B companies, including notable clients like Qualtrics and Adobe, in forecasting business performance, managing pipelines, and minimizing customer churn.

Decodable is a data integration and engineering platform focused on serverless streaming data, founded in 2021 and based in San Francisco, California. The company provides software that enables applications and data engineers to construct complex data pipelines efficiently. Its platform facilitates quick connections to various messaging, storage, and database systems, allowing users to collect, process, and deliver data effectively to both offline and online systems.

EarnUp Inc. is a fintech company based in San Francisco, California, that focuses on automating loan payments for consumers. Established in 2013, EarnUp's platform is designed to assist over 200 million Americans managing various types of debt, including home mortgages, student loans, auto loans, and personal loans. The platform allows users to set aside small amounts of money when they can afford it, which are then allocated for loan payments, helping users pay off their debts more efficiently. By syncing micro-payments with individual income and automating savings in real-time, EarnUp aims to alleviate the stress of financial management and empower users to take control of their financial situations.

Xilio Therapeutics is a clinical-stage biotechnology company focused on developing innovative immunotherapies to enhance the immune system's ability to combat cancer. The company specializes in tumor-selective immunotherapies that leverage its proprietary technology to maximize the effectiveness of existing immuno-oncology treatments while minimizing side effects outside the tumor. Its lead product, XTX201, is designed to induce immune activity specifically within tumors, demonstrating improved antitumor efficacy. Xilio Therapeutics aims to deliver significant improvements in patient outcomes by utilizing its platform to create a pipeline of novel therapies, including tumor-activated cytokines, antibodies, and immune cell engagers, all targeted to optimize therapeutic effects within the tumor microenvironment. Founded in 2015 and based in Waltham, Massachusetts, the company was previously known as Akrevia Therapeutics before rebranding in March 2020.

Reprise, Inc. is a company that specializes in developing a demo creation platform for sales and marketing teams. Founded in 2019 and based in Jackson, Wyoming, Reprise's platform allows users to create, edit, and deploy software product demos by capturing screens via the browser. It provides tools to customize demos, including modifying text, data, and screen flows, while ensuring the integrity of the presentation by locking the replay as designed. This capability enables businesses to produce tailored product tours and emailable experiences, ultimately helping them enhance conversions, shorten sales cycles, and drive revenue growth.

River 3 Renal is a developer of novel therapies designed to target orphan diseases in the renal space. The company's technology has the potential to address the unmet need in several kidney diseases, by further improving the standard of care, enabling medical practitioners to treat patients in a better way. River 3 Renal was established in 2020 in New York, USA.

Multi-Specialty HealthCare operates more than 30 patient care centers throughout the Baltimore-Washington metropolitan area and the Delmarva Peninsula. It employs a patient-centric, integrated model focused on delivering high-quality care to individuals injured in automobile and workplace accidents, regardless of their health insurance status. The company has a team of general practice and urgent care physicians, chiropractors, orthopedists, and other medical specialists who provide a full spectrum of treatment including physical rehabilitation, medical care, and other ancillary services.

TeachTown Inc. specializes in developing educational solutions for children diagnosed with autism spectrum disorder, developmental disabilities, intellectual disabilities, and emotional and behavioral disorders. The company's flagship products include TeachTown Basics, a computer-assisted instructional program that combines engaging computer lessons with motivating off-computer activities, and TeachTown Social Skills, an online curriculum that utilizes character-based video modeling to enhance social skills in elementary and middle school children. Additionally, TeachTown provides professional development resources for educators, enabling them to effectively implement its programs in the classroom. With a focus on improving academic, social, and emotional skills, TeachTown serves schools, families, and clinicians, facilitating the educational growth of children with special needs. Founded in 2001 and based in Woburn, Massachusetts, the company has positioned itself as a key resource in the field of special education.

EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on transforming the drug discovery and delivery process to address the rising costs of medicines. Founded in 2019, EQRx aims to provide a market-based solution by leveraging advances in science and technology while collaborating with various healthcare stakeholders. The company has over ten programs in its pipeline targeting oncology and immune-inflammatory conditions, which include clinical and preclinical stages, as well as drug engineering initiatives. Among its key programs are Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab. Through its innovative approach, EQRx seeks to develop high-quality, patent-protected medicines more efficiently and cost-effectively than traditional pharmaceutical methods.

Specto is a mobile application performance monitoring platform founded in 2019 and based in San Francisco, California. The platform is designed for developers, allowing them to collect essential metrics and profiles with minimal code integration. Specto's proprietary dashboard provides insights into mobile application performance, helping businesses understand the reasons behind specific performance issues. By combining data analysis with industry expertise, the platform enables clients to identify root causes and offers actionable recommendations to enhance application performance. Specto emphasizes ease of integration and provides hands-on support to ensure a smooth user experience.

Vesta Corporation is a provider of electronic payment solutions, specializing in client-branded services that enhance payment processing for merchants. The company offers a range of merchant solutions, including vSafe for Small to Midsize Businesses, which focuses on payment and fraud protection for smaller digital goods merchants, and vSafe for Enterprise, designed for comprehensive payments management and enterprise-level fraud prevention. Additionally, Vesta provides vGuaranteed, a payment solution tailored for online retailers, and DelayPay, a retail installment program that allows prepaid wireless customers to pay for services in installments. Founded in 1995 and headquartered in Lake Oswego, Oregon, Vesta operates globally, with centers in the United States, Ireland, China, and an office in Singapore. The company serves diverse industries, including e-commerce, telecommunications, and financial services, processing hundreds of millions of secure payments across various channels while prioritizing data security and fraud loss elimination.

Solid Biosciences Inc. is a life science company focused on developing therapies for Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease primarily affecting boys. The company's lead product candidate, SGT-001, is a gene transfer therapy currently undergoing a Phase I/II clinical trial aimed at restoring functional dystrophin protein expression in patients' muscles. In addition to SGT-001, Solid Biosciences is advancing the Anti-LTBP4 program, which involves a monoclonal antibody designed to reduce fibrosis and inflammation by targeting the LTBP4 protein. The company also develops biomarkers and sensors, as well as the Solid Suit program, which focuses on creating wearable assistive devices with functional and therapeutic benefits. Founded in 2013 and headquartered in Cambridge, Massachusetts, Solid Biosciences has established a strategic collaboration with Ultragenyx to enhance gene therapy development for DMD. With no current cure for DMD, the company aims to provide innovative solutions for a condition that affects an estimated 10,000 to 15,000 cases in the United States.